.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Baxter
AstraZeneca
Cerilliant
McKesson
QuintilesIMS
Julphar
Accenture
Chubb
US Department of Justice

Generated: July 24, 2017

DrugPatentWatch Database Preview

ATROPINE AND DEMEROL Drug Profile

« Back to Dashboard

Which patents cover Atropine And Demerol, and what generic Atropine And Demerol alternatives are available?

Atropine And Demerol is a drug marketed by Abbvie and is included in three NDAs.

The generic ingredient in ATROPINE AND DEMEROL is atropine sulfate; meperidine hydrochloride. There are twenty-two drug master file entries for this compound. Additional details are available on the atropine sulfate; meperidine hydrochloride profile page.

Summary for Tradename: ATROPINE AND DEMEROL

Patents:0
Applicants:1
NDAs:3
Clinical Trials: see list105,123
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ATROPINE AND DEMEROL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
ATROPINE AND DEMEROL
atropine sulfate; meperidine hydrochloride
INJECTABLE;INJECTION087847-001Nov 26, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbvie
ATROPINE AND DEMEROL
atropine sulfate; meperidine hydrochloride
INJECTABLE;INJECTION087848-001Nov 26, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Abbvie
ATROPINE AND DEMEROL
atropine sulfate; meperidine hydrochloride
INJECTABLE;INJECTION087853-001Nov 26, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Novartis
Argus Health
Fish and Richardson
Boehringer Ingelheim
Merck
Daiichi Sankyo
Accenture
Deloitte
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot